Fluent Financial, LLC Dexcom Inc Transaction History

Fluent Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$84.98 - $122.67 $1.45 Million - $2.1 Million	-17,120 Reduced 76.82%	5,166 $584,000
Q3 2022 Oct 31, 2022	SELL	$76.35 - $94.18 $437,867 - $540,122	-5,735 Reduced 20.47%	22,286 $1.8 Million
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $1.55 Million - $3.02 Million	22,757 Added 432.31%	28,021 $2.09 Million
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $495,237 - $685,372	5,264 New	5,264 $2.71 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Fluent Financial, LLC with notifications on news.